Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 8, 2013, Pages 1574-1584

  Li, Hua Ping ^a   Chen, Xuan ^b   Li, Ming Qing ^c  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b First Hospital of Wujiang City   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

cell; Diabetes; GDM; Pancreatic islet; Sodium butyrate

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE;

ANIMAL; ARTICLE; C57BL MOUSE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GDM; INSULIN RESISTANCE; LIPID DIET; METABOLISM; MOUSE; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; Β-CELL;

DIABETES; GDM; PANCREATIC ISLET; SODIUM BUTYRATE; Β-CELL;

ANIMALS; BUTYRATES; DIET, HIGH-FAT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MICE; MICE, INBRED C57BL; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84882982287     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005; 54: 108-113.
2. Zhang H, Zhang J, Pope CF, Crawford LA, Vasavada RC, Jagasia SM, Gannon M. Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes 2010; 59: 143-152.
3. Rieck S, White P, Schug J, Fox AJ, Smirnova O, Gao N, Gupta RK, Wang ZV, Scherer PE, Keller MP, Attie AD and Kaestner KH. The Transcriptional Response of the Islet to Pregnancy in Mice. Mol Endocrinol 2009; 23: 1702-1712.
4. Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. Arch Physiol Biochem 2009; 115: 240-247.
5. Rieck S, Kaestner KH. Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 2010; 21: 151-158.
6. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011; 3: 858-876.
7. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17: 1519-1528.
8. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133: 2485S-2493S.
9. Christensen DP, Dahllöf M, Lundh M, Rasmussen DN, Nielsen MD, Billestrup N, Grunnet LG, Mandrup-Poulsen T. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol Med 2011; 17: 378-390.
10. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice. Diabetes 2009; 58: 1509-1517.
11. Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J, Jia W. Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. Diabetes 2012; 61: 797-806.
12. Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ. Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms. PLoS One 2012; 7: e35240.
13. Soliman MM, Ahmed MM, Salah-Eldin AE, Abdel-Aal AA. Butyrate regulates leptin expression through different signaling pathways in adipocytes. J Vet Sci 2011; 12: 319-323.
14. Suh HS, Choi S, Khattar P, Choi N, Lee SC. Histone deacetylase inhibitors suppress the ex-pression of inflammatory and innate immune response genes in human microglia and astrocytes. J Neuroimmune Pharmacol 2010; 5: 521-532.
15. Halili MA, Andrews MR, Labzin LI, Schroder K, Matthias G, Cao C, Lovelace E, Reid RC, Le GT, Hume DA, Irvine KM, Matthias P, Fairlie DP, Sweet MJ. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. J Leukoc Biol 2010; 87: 1103-1114.
16. Buettner R, Schölmerich J, Bollheimer LC. High-fat Diets: Modeling the Metabolic Disorders of Human Obesity in Rodents. Obesity 2007; 15: 798-808.
17. Jones HN, Woollett LA, Barbour N, Prasad PD, Powell TL, Jansson T. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J 2009; 23: 271-278.
18. Winzell MS, Magnusson C, Ahrén B. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice. Metabolism 2007; 56: 122-128.
19. Serre-Beinier V, Toso C, Morel P, Gonelle-Gispert C, Veyrat-Durebex C, Rohner-Jeanrenaud F, Calandra T, Roger T, James RW, Montet X, Bühler L, Bosco D, Berney T. Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. J Endocrinol 2010; 206: 297-306.
20. Gallou-Kabani C, Vigé A, Gross MS, Rabès JP, Boileau C, Larue-Achagiotis C, Tomé D, Jais JP, Junien C. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 2007; 15: 1996-2005.
21. Huang HH, Novikova L, Williams SJ, Smirnova IV, Stehno-Bittel L. Low insulin content of large islet population is present in situ and in isolated islets. Islets 2011; 3: 6-13.
22. Howarth FC, Marzouqi FM, Al Saeedi AM, Hameed RS, Adeghate E. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induceddiabetic rat. JOP 2009; 10: 485-491.
23. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C, Butler PC. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
24. Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI. A Pentadecapeptide Fragment of Islet Neogenesis-Associated Protein Increases Beta-Cell Mass and Reverses Diabetes in C57BL/6J Mice. Ann Surg 2004; 240: 875-884.
25. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
26. Bouwens L, Rooman I. Regulation of Pancreatic Beta-Cell Mass. Physiol Rev 2005; 85: 1255-1270.
27. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E. beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord 2008; 9: 329-343.
28. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 2010; 11: 897-904.
29. Mandrup-Poulsen T. IAPP boosts islet macrophage IL-1 in type 2 diabetes. Nat Immunol 2010; 11: 881-883.
30. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155: 173-181.
31. Mankan AK, Lawless MW, Gray SG, Kelleher D, McManus R. NF-kappaB regulation: the nuclear response. J Cell Mol Med 2009; 13: 631-643.
32. Alvaro A, Solà R, Rosales R, Ribalta J, Anguera A, Masana L, Vallvé JC. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life 2008; 60: 757-764.
33. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN. Insulin receptors in β cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 2007; 104: 8977-8982.
34. Brice KR, Tzefos MK. The Clinical Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Agonists in Adults with Type 2 Diabetes Mellitus. Clin Med Insights Endocrinol Diabetes 2011; 4: 13-24.
35. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 Stimulates Both b-Cell Replication and Neogenesis, Resulting in Increased b-Cell Mass and Improved Glucose Tolerance in Diabetic Rats. Diabetes 1999; 48: 2270-2276.
36. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL.--- Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005; 54: S97-S107.
37. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G. Glucolipotoxicity of the Pancreatic Beta Cell. Biochim Biophys Acta 2010; 1801: 289-298.
38. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 2006; 55: S16 -S23.
39. Sanz Y, Santacruz A, De Palma G. Insights into the Roles of Gut Microbes in Obesity. Interdiscip Perspect Infect Dis 2008; 2008: 829101.
40. Calao M, Burny A, Quivy V, Dekoninck A, Van Lint C. A pervasive role of histoneacet yltransferases and deacetylases in an NF-kB-signaling code. Trends Biochem Sci 2008; 33: 339-349.